Charlotte’s Milestone Pharmaceuticals advancing heart drug
Joseph Oliveto, Milestone’s president and chief executive officer, said he expected the FDA to render a decision on the drug in about a year from now.
Read MorePharmaceuticals
Merz Therapeutics buying two drugs for $185 million
One of the drugs is for the treatment of “off” phases of Parkinson’s disease called Inbrija. The other drug is for the treatment of gait disorders in multiple sclerosis called Ampyra.
Read MoreJapan-based Kyowa Kirin to invest $200 million for new pharma manufacturing complex in Sanford
Kyowa Kirin North America (KKNA) expects to create 102 new jobs and will invest $200 million in Sanford.
Read More
Japanese pharmaceutical company to open in Sanford, create over 100 new jobs, NC officials say
In exchange for the 102 jobs and millions of dollars in promised capitol investment in Lee County, Kyowa Kirin will receive over $10 million in state and local incentives.
Read More
FDA approves Eli Lilly’s diabetes drug Zepbound; production underway in Durham
The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
Read More
CliniSpan Health brings diversification to clinical health trials
Chapel Hill-based startup CliniSpan Health is working to increase the presence of minorities in clinical health trials.
Read More
Durham biotech startup ScitoVation targets $750,000 in fundraiser
Founded in 2016, ScitoVation works with clients to develop safer pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products.
Read More
Durham’s Fennec reports Q3 loss, despite progress with trademark drug
Durham-based Fennec Pharmaceuticals reported a net loss of $2.7 million for the third quarter of 2018, even though the company says it’s making progress in regulatory submissions for its trademark drug, Pedmark. Read more here.
Read More
